MRNS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Marinus Pharmaceuticals (MRNS) Earnings Date & Reports

Industry: @Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

MRNS is expected to report earnings to fall 26.26% to -30 cents per share on March 11

Marinus Pharmaceuticals MRNS Stock Earnings Reports

Q4'24

Est.

$-0.31

Q3'24

Missed

by $0.01

Q2'24

Missed

by $0.04

Q1'24

Missed

by $0.03

Q4'23

Missed

by $0.12

The last earnings report on November 12 showed earnings per share of -41 cents, missing the estimate of -40 cents. With 1.39M shares outstanding, the current market capitalization sits at 29.81M.

View a ticker or compare two or three

Compare

MRNS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MRNS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of innovative neuropsychiatric therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

100 Matsonford Road

Phone

+1 484 801-4670

Employees

165

Web

https://www.marinuspharma.com